表紙:セントラルラボの市場規模、シェア、成長分析、サービス別、エンドユーザー別、地域別 - 産業予測、2025~2032年
市場調査レポート
商品コード
1796138

セントラルラボの市場規模、シェア、成長分析、サービス別、エンドユーザー別、地域別 - 産業予測、2025~2032年

Central Lab Market Size, Share, and Growth Analysis, By Services (Biomarker Services, Genetic Services), By End-User (Pharmaceutical Companies, Biotechnology Companies), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 195 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
セントラルラボの市場規模、シェア、成長分析、サービス別、エンドユーザー別、地域別 - 産業予測、2025~2032年
出版日: 2025年08月12日
発行: SkyQuest
ページ情報: 英文 195 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セントラルラボの世界市場規模は2023年に30億米ドルと評価され、2024年の31億9,000万米ドルから2032年には52億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.4%で成長する見通しです。

世界のセントラルラボ市場は、効率的な臨床試験プロセスに対する要求の高まり、複雑化する医薬品市場開拓、費用対効果の高い集中診断サービスに対するニーズなどを背景に、大きな成長を遂げています。ラボの自動化における革新、医薬品研究開発への投資の増加、CROやバイオテクノロジー企業による統合ラボサービスの利用の高まりがこの傾向に寄与しています。AI、機械学習、クラウドベースのシステムなどの技術は、ラボ業務を強化し、臨床試験の成果を迅速化しています。さらに、個別化医療とバイオマーカー検査の急増は、正確性と適時性のために集中型ラボモデルへの依存を助長しています。デジタル統合とデータ精度の向上が市場の可能性を高める一方で、高額な初期投資やデータセキュリティの問題などの課題が、特に新興国市場では一時的な制約となる可能性があります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • ケーススタディ
  • 顧客購買行動分析

セントラルラボ市場規模:サービス別& CAGR(2025-2032)

  • 市場概要
  • バイオマーカーサービス
  • 遺伝子サービス
  • 微生物学サービス
  • 特殊化学サービス
  • 組織学
  • 標本管理と保管

セントラルラボ市場規模:計装別& CAGR(2025-2032)

  • 市場概要
  • 自動分析装置
  • 顕微鏡検査
  • 分光分析
  • クロマトグラフィー
  • 電気泳動

セントラルラボ市場規模:技術別& CAGR(2025-2032)

  • 市場概要
  • ポリメラーゼ連鎖反応(PCR)
  • 免疫組織化学
  • フローサイトメトリー
  • 質量分析
  • 次世代シーケンシング

セントラルラボ市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 製薬会社
  • バイオテクノロジー企業
  • 学術
  • 調査機関

セントラルラボ市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • ACM Global Laboratories
  • Eurofins Scientific
  • ICON plc
  • Labcorp
  • Thermo Fisher Scientific
  • Cerba Research
  • Medicover Integrated Clinical Services
  • Medspace
  • Bioscientia
  • Barc Lab
  • CIRION BioPharma Research

結論と提言

目次
Product Code: SQMIG35D2345

Global Central Lab Market size was valued at USD 3.0 billion in 2023 and is poised to grow from USD 3.19 billion in 2024 to USD 5.24 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The Global Central Lab market is experiencing significant growth driven by increasing demands for efficient clinical trial processes, the complexities of drug development, and a need for cost-effective centralized diagnostic services. Innovations in laboratory automation, rising investments in pharmaceutical research and development, and the heightened use of integrated lab services by CROs and biotech firms contribute to this trend. Technologies like AI, machine learning, and cloud-based systems are enhancing lab operations and expediting clinical study outcomes. Furthermore, the surge in personalized medicine and biomarker testing is fostering a reliance on centralized lab models for accuracy and timeliness. While digital integration and improved data accuracy bolster market potential, challenges such as high initial investments and data security issues may pose temporary constraints, especially in developing regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Central Lab market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Central Lab Market Segments Analysis

Global Central Lab Market is segmented by Services, End-User and region. Based on Services, the market is segmented into Biomarker Services, Genetic Services, Microbiology Services, Special Chemistry Services, Histology and Specimen Management & Storage. Based on End-User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Central Lab Market

The central lab market is experiencing significant growth driven by the increasing number of clinical trials, especially in areas such as oncology, rare diseases, and vaccines. Central labs offer consistent testing, standardized data management, and rapid reporting across various study locations, which are essential for enhancing trial efficiency and reliability. As multinational pharmaceutical companies expand their portfolios, there is a heightened demand for laboratories that can ensure regulatory compliance while also optimizing operational performance. This trend reflects the broader shift towards more complex and diverse research endeavors, further underscoring the importance of central labs in contemporary clinical development.

Restraints in the Global Central Lab Market

The Global Central Lab market faces significant constraints due to the substantial investment required for establishing and maintaining central lab facilities. This includes high expenditures for specialized equipment, advanced technology platforms, data management systems, and the recruitment of skilled personnel. These considerable capital and ongoing operational costs create barriers for smaller laboratories and emerging contract research organizations, ultimately restricting their potential for growth and market penetration. As a result, the financial burden associated with developing and continuing lab operations can hinder innovation and limit the overall expansion of the market.

Market Trends of the Global Central Lab Market

The Global Central Lab market is witnessing a notable trend driven by the increasing adoption of outsourcing among pharmaceutical and biotechnology firms. This shift allows these organizations to leverage enhanced scalability, extensive international trial coverage, and improved regulatory harmonization, which are critical for navigating the complexities of clinical trials. As companies seek to optimize resources and streamline operations, central lab services are becoming increasingly essential, offering specialized expertise and cutting-edge technology. This trend is anticipated to enhance operational efficiencies while also facilitating faster and more reliable data collection and analysis, ultimately contributing to the acceleration of drug development timelines and improved patient outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Central Lab Market Size by Services & CAGR (2025-2032)

  • Market Overview
  • Biomarker Services
  • Genetic Services
  • Microbiology Services
  • Special Chemistry Services
  • Histology
  • Specimen Management & Storage

Global Central Lab Market Size by Instrumentation & CAGR (2025-2032)

  • Market Overview
  • Automated Analyzers
  • Microscopy
  • Spectrometry
  • Chromatography
  • Electrophoresis

Global Central Lab Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry
  • Flow Cytometry
  • Mass Spectrometry
  • Next Generation Sequencing

Global Central Lab Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academics
  • Research Institutes

Global Central Lab Market Size & CAGR (2025-2032)

  • North America (Services, Instrumentation, Technology, End-User)
    • US
    • Canada
  • Europe (Services, Instrumentation, Technology, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Services, Instrumentation, Technology, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Services, Instrumentation, Technology, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Instrumentation, Technology, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • ACM Global Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labcorp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerba Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicover Integrated Clinical Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medspace
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioscientia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Barc Lab
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CIRION BioPharma Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations